Neuroscientists target Alzheimer’s “silent stage”
The latest research into what is known as the “silent stage” of Alzheimer’s disease has prompted many experts to believe that early intervention may offer the best chance of therapeutic success.
The “silent stage” of Alzheimer’s concerns what goes on inside the brain before symptoms appear and is today a major focus of current research. Neuroscientists are particularly interested in the different types of protein that build up in the brain, sometimes 20 years before Alzheimer’s symptoms appear. These proteins cause damage to the neurons we need to remain cognitively healthy.
Rising Physician Dissatisfaction in Europe Signals an Urgent Need for Change
In the two years since we last surveyed physicians working on the front line of European healthcare, their discontent has risen to an alarming level. Many say they would not recommend their hospital as a place to work or to receive care. Physicians and surgeons also have grown increasingly dissatisfied with pharma companies and medtech manufacturers over the past two years.
Citing staffing shortages, budget cuts, ageing equipment and inadequate facilities, physicians warn they are unprepared to cope with looming healthcare challenges, including ageing populations and the reemergence of infectious diseases (see Figure 1). In addition to inadequate resources, physicians also cite a lack of unbiased information, which impedes sound decision making. More than 70% say they are dissatisfied with the information pharma and medtech companies provide.
